Commentary|Videos|June 5, 2024
The Importance of Early Referral and Interdisciplinary Care in MS: Kathy Zackowski, PhD, OTR
Author(s)Kathy Zackowski, PhD, OTR
Fact checked by: Marco Meglio
The associate vice president of research at National MS Society talked about proactive and early referral to rehabilitation services to effectively manage multiple sclerosis symptoms from the outset. [WATCH TIME: 4 minutes]
Advertisement
WATCH TIME: 4 minutes
"Having an occupational therapist to go to and ask questions, [as well as to] try different strategies that might be really personalized to your particular situation can be really helpful to patients with [multiple sclerosis]."
Research shows that rehabilitation therapy is a beneficial aspect of care for patients living with multiple sclerosis (MS), a chronic debilitating disease characterized by demyelination of the nerves of the central nervous system.1 Rehabilitation therapy can assist patients with regaining or retaining function and improving their physical, mental, and social wellbeing. There are several forms of rehabilitation therapy currently available for patients including physical rehabilitation methods, such as balance and gait therapy, speech and respiration rehabilitation, and occupational therapy.
Studies reveal that the structure of the care team can impact patient outcomes, and that both in- and out-patient care settings may be beneficial, dependent on the patient's circumstances. Clinicians also recommend that patients have a multidisciplinary care team for rehabilitation and regular reassessment for managing changing symptoms. Research has demonstrated that the critical components of rehabilitation include the patients' participation in the intervention, goal setting with a multidisciplinary care team, and a guiding-light purpose for the patient, which focuses on recognition of their personal potential and obtaining improvements in a tailored plan.1
REFERENCES
1. Iodice R, Aceto G, Ruggiero L, Cassano E, Manganelli F, Dubbioso R. A review of current rehabilitation practices and their benefits in patients with multiple sclerosis. Mult SclerRelatDisord. 2023;69:104460. doi:10.1016/j.msard.2022.104460
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- NeurologyLive® Friday 5 — September 12, 2025
September 12th 2025
- Expanding the Alzheimer Drug Development Pipeline
September 12th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
Expanding the Alzheimer Drug Development Pipeline
2
DORAs Carry Lower Real-World Abuse, New Phase 3 Argus Data, RAP-219 Meets Primary End Point
3
MDA and PPMD Release Consensus Guidelines for Safe and Equitable Use of Gene Therapy in Duchenne
4
NeurologyLive® Friday 5 — September 12, 2025
5